Synthesis and in Vitro Antimalarial Testing of Neocryptolepines: SAR Study for Improved Activity by Introduction and Modifications of Side Chains at C2 and C11 on Indolo[2,3‑b]quinolines

• Published in: Journal of medicinal chemistry Vol. 56; no. 4; pp. 1431 - 1442
• Main Authors: Mei, Zhen-Wu, Wang, Li, Lu, Wen-Jie, Pang, Cui-Qing, Maeda, Tsukasa, Peng, Wei, Kaiser, Marcel, El Sayed, Ibrahim, Inokuchi, Tsutomu
• Format: Journal Article
• Language: English
• Published: WASHINGTON American Chemical Society 28.02.2013; Amer Chemical Soc
• Subjects: Alkaloids - chemical synthesis; Alkaloids - chemistry; Alkaloids - pharmacology; Animals; Antimalarials - chemical synthesis; Antimalarials - chemistry; Antimalarials - pharmacology; Cell Line; Chemistry, Medicinal; Chloroquine - pharmacology; Drug Resistance; Indoles - chemical synthesis; Indoles - chemistry; Indoles - pharmacology; Life Sciences & Biomedicine; Malaria - drug therapy; Mice; Parasitic Sensitivity Tests; Pharmacology & Pharmacy; Plasmodium berghei; Plasmodium falciparum - drug effects; Quinolines - chemical synthesis; Quinolines - chemistry; Quinolines - pharmacology; Rats; Science & Technology; Structure-Activity Relationship; ANTIPLASMODIAL ACTIVITY; CRYPTOLEPINE; TRYPANOSOMA-BRUCEI; INHIBITION; FORMAL SYNTHESIS; INDOLOQUINOLINE ALKALOIDS; PLASMODIUM-FALCIPARUM; NATURAL-PRODUCTS; MEDIATED SYNTHESIS; CHLOROQUINE
• ISSN: 0022-2623; 1520-4804
• DOI: 10.1021/jm300887b

To obtain a high antimalarial activity with neocryptolepine derivatives, modifying and changing the side chains at the C11 position with varying the substituents of an electron-withdrawing or electron-donating nature at the C2 position for a SAR study were executed. Installation of alkylamino and ω-aminoalkylamino groups at the C11 position of the neocryptolepine core was successful. For further variation, the aminoalkylamino substituents were transformed into the corresponding acyclic or cyclic carbamides or thiocarbamides. These side chain modified neocryptolepine derivatives were tested for antimalarial activity against CQR (K1) and CQS (NF54) of Plasmodium falciparum in vitro and for cytotoxicity toward mammalian L6 cells. Among the tested compounds, the compound 17f showed an IC50 of 2.2 nM for CQS (NF54) and a selectivity index of 1400, and 17i showed an IC50 of 2.2 nM for CQR (K1), a selectivity index of 1243, and a resistance index of 0.5.